Liquid PedvaxHIB Interactions
There are 298 drugs known to interact with Liquid PedvaxHIB (haemophilus b conjugate (prp-omp) vaccine). Of the total drug interactions, 1 is major, 295 are moderate, and 2 are minor.
- View all 298 medications that may interact with Liquid PedvaxHIB
Most frequently checked interactions
View interaction reports for Liquid PedvaxHIB (haemophilus b conjugate (prp-omp) vaccine) and the medicines listed below.
- ActHIB (haemophilus b conjugate (prp-t) vaccine)
- Ajovy (fremanezumab)
- Amitiza (lubiprostone)
- amitriptyline
- amoxicillin / clavulanate
- Aquoral (saliva substitutes topical)
- atorvastatin
- B-12 (cyanocobalamin)
- biotin
- Botox (onabotulinumtoxinA)
- cephalexin
- chlordiazepoxide / clidinium
- cortisone
- Daptacel (DTaP) (diphtheria and tetanus toxoids / pertussis, acellular)
- duloxetine
- Engerix-B Pediatric (hepatitis b pediatric vaccine)
- erythromycin ophthalmic
- estradiol
- fluconazole
- fluticasone nasal
- gabapentin
- Gardasil 9 (human papillomavirus vaccine)
- Havrix Pediatric (hepatitis a pediatric vaccine)
- Hiberix (haemophilus b conjugate (prp-t) vaccine)
- hydrocodone
- hydroxychloroquine
- hyoscyamine
- Infanrix (DTaP) (diphtheria and tetanus toxoids / pertussis, acellular)
- Ipol (poliovirus vaccine, inactivated)
- Kinrix (diphtheria toxoid / pertussis, acellular / poliovirus vaccine, inactivated / tetanus toxoid)
More about Liquid PedvaxHIB (haemophilus b conjugate (prp-omp) vaccine)
- Liquid PedvaxHIB consumer information
- Compare alternatives
- Pricing & coupons
- Side effects
- Dosage information
- During pregnancy
- Drug class: bacterial vaccines
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.